SCHEMBL26310529

SCHEMBL26310529

CCC1(C)OB(c2cc(Cl)c(OCCS(C)(C)C)c(C(=O)NC(C)(C)CC(C)(C)C)c2)OC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21261994 0.93 AAK1 (0.37) AAK1
SCHEMBL26310600 0.83 DGAT1 (0.32) AAK1
SCHEMBL21246816 0.82 AAK1 (0.38) AAK1
SCHEMBL30137168 0.80 AAK1 (0.39) AAK1
SCHEMBL21246858 0.80 AAK1 (0.39) AAK1
SCHEMBL21262029 0.74 AAK1 (0.38) AAK1
SCHEMBL26310727 0.73 HTT (0.32)
SCHEMBL22569499 0.72 POLB (0.42)
SCHEMBL21246698 0.71 DGAT1 (0.33) AAK1
SCHEMBL21246868 0.71 DGAT1 (0.35) AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728267-B1 TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RES OICR (CA) 2023-09-13 EP disclosed